D.E. Shaw & Co’s Select Medical SEM Stock Holding History

D.E. Shaw & Co’s Portfolio SEM Stock Details SEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-42,874	Closed	-$333K	–	3963
2014 Q4	$333K	Hold	42,874	–	–	﹤0.01%	3591
2014 Q3	$278K	Buy	+42,874	New	+$331K	﹤0.01%	3729

Other funds holding SEM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

D.E. Shaw & Co's SEM Position: Q1 2026 in Review

D.E. Shaw & Co reduced its Select Medical (SEM) stake by 38% in Q1 2026, selling an estimated $13.3M and leaving 1,360,925 shares worth $22.2M. The position accounts for 0.01% of the portfolio, ranked #1089.

D.E. Shaw & Co first reported a position in SEM in Q2 2013 and has held it in 46 quarters since. The position peaked at $32.8M in Q4 2025. 277 funds tracked by Wall St. Rank hold SEM as of Q1 2026.

D.E. Shaw & Co held 1,360,925 shares of Select Medical worth $22.2M as of Q1 2026.
D.E. Shaw & Co sold 850,973 Select Medical shares in Q1 2026, an estimated $13.3M.
Select Medical made up 0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #1089 holding.
D.E. Shaw & Co first reported a position in Select Medical in Q2 2013 and has held it in 46 quarters since.
D.E. Shaw & Co's Select Medical position peaked at $32.8M in Q4 2025.
277 funds tracked by Wall St. Rank held Select Medical as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.